((S)-2-chloromethyl-3-methyl-butoxymethyl)-benzene | 1067910-86-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ((S)-2-chloromethyl-3-methyl-butoxymethyl)-benzene
• 英文别名: [(2S)-2-(chloromethyl)-3-methylbutoxy]methylbenzene
• CAS: 1067910-86-4
• 化学式: C₁₃H₁₉ClO
• 分子量: 226.746
• InChiKey: LVBDRNBFPMOXLN-CYBMUJFWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  ((S)-2-chloromethyl-3-methyl-butoxymethyl)-benzene 在 (+)-鹰爪豆碱 二异丁基氢化铝 作用下， 以 四氢呋喃 、 二氯甲烷 、 二甲基亚砜 、 乙腈 为溶剂， 反应 5.0h， 生成 (2S,4S,5S,7S)-7-benzyloxymethyl-2-isopropyl-8-methyl-4-nitro-nonane-1,5-diol
  参考文献：
  名称：

  WO2008/119804

  摘要：

  公开号：

文献信息

• METHODS
  申请人：Sedelmeier Gottfried

  公开号：US20100130749A1

  公开（公告）日：2010-05-27

  The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren Inter alia the invention relates to a process for the manufacture of a compound of the formula I. or a salt thereof, wherein R1 as well as Act are as defined in the specification, and processes of manufacturing this compound as well as intermediates in this process.

  本发明涉及一种新的过程、新的过程步骤和新的中间体，适用于合成药物活性化合物，特别是肾素抑制剂，如阿利司他。此外，本发明还涉及一种制备式I化合物或其盐的方法，其中R1和Act如规范中定义，以及制备该化合物和该过程中的中间体的方法。
• ORGANIC COMPOUNDS
  申请人：Mickel Stuart John

  公开号：US20100274027A1

  公开（公告）日：2010-10-28

  The invention provides a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Allskiren. Inter alia, the invention provides a process for the manufacture of a compound of the formula III, wherein R, R 1 , R 2 , R 3 and PG are as defined in the specification, or a salt thereof. The manufacture comprises (preferably consists of) reacting a compound of the formula I, with a reagent able to transform hydroxy into X where X is for example a leaving group.

  本发明提供了一种新的过程、新的过程步骤和新的中间体，用于合成药物活性化合物，特别是肾素抑制剂，例如Allskiren。此外，本发明还提供了一种制备式III化合物或其盐的方法，其中R、R1、R2、R3和PG如规范中所定义。该制备方法包括（最好是由）将式I化合物与能够将羟基转化为X的试剂反应，其中X例如是一个离去基团。
• Organic Compounds
  申请人：Mickel Stuart John

  公开号：US20080207921A1

  公开（公告）日：2008-08-28

  The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula III, wherein R, R 1 , R 2 , R 3 and PG are as defined in the specification, or a salt thereof, said manufacture comprising (preferably consisting in) reacting a compound of the formula I,

  本发明涉及一种新颖的过程、新颖的过程步骤和新颖的中间体，用于合成药物活性化合物，特别是肾素抑制剂，如阿利司他。此外，本发明涉及一种制备式III化合物的过程，其中R、R1、R2、R3和PG如规范中所定义，或其盐，所述制备包括（最好是由）反应式I化合物。
• Process for preparing renin inhibitors
  申请人：Novartis AG

  公开号：US07767831B2

  公开（公告）日：2010-08-03

  The present invention provides a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention provides a process for the manufacture of a compound of the formula III, wherein R, R1, R2, R3 and PG are as defined in the specification, or a salt thereof. The manufacture comprises (preferably consists of) reacting a compound of the formula I, with a reagent able to transform hydroxy into X where X is for example a leaving group.

  本发明提供了一种新颖的过程、新颖的过程步骤和新颖的中间体，可用于合成药物活性化合物，特别是肾素抑制剂，如阿利司他。此外，本发明提供了一种用于制造公式III化合物或其盐的方法，其中R、R1、R2、R3和PG如规范中所定义。制造包括（最好仅包括）将公式I化合物与能将羟基转化为X的试剂反应，其中X例如是一个离去基团。
• Organic compounds
  申请人：Novartis AG

  公开号：EP2080754A2

  公开（公告）日：2009-07-22

  The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula III, wherein R, R1, R2, R3 and PG are as defined in the specification, or a salt thereof, said manufacture comprising (preferably consisting in) reacting a compound of the formula I, with a reagent able to transform hydroxy into X where X is for example a leaving group.

  本发明涉及一种新型工艺、新型工艺步骤和新型中间体，这些工艺、步骤和中间体可用于合成具有医药活性的化合物，特别是肾素抑制剂，如阿利吉仑。除其他外，本发明涉及一种制造式 III 化合物的工艺、 其中 R、R1、R2、R3 和 PG 如说明书中所定义，或其盐，所述制造过程包括（最好包括） 使式 I 的化合物反应 与能将羟基转化为 X 的试剂反应，其中 X 例如为离去基团。